Malleability of Short Telomeres by Telomerase Activators: A Mini-review
暂无分享,去创建一个
[1] C. Harley,et al. A natural product telomerase activator as part of a health maintenance program: metabolic and cardiovascular response. , 2013, Rejuvenation research.
[2] G. Paolisso,et al. A new pleiotropic effect of statins in elderly: modulation of telomerase activity , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] G. Paolisso,et al. Mediterranean Diet, Telomere Maintenance and Health Status among Elderly , 2013, PloS one.
[4] M. Armanios. Telomeres and age-related disease: how telomere biology informs clinical paradigms. , 2013, The Journal of clinical investigation.
[5] E. Epel,et al. A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity , 2013, International journal of geriatric psychiatry.
[6] A. Newman,et al. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? , 2013, Epidemiologic reviews.
[7] E. Epel,et al. Changes in stress, eating, and metabolic factors are related to changes in telomerase activity in a randomized mindfulness intervention pilot study , 2012, Psychoneuroendocrinology.
[8] V. Boccardi,et al. Telomerase gene therapy: a novel approach to combat aging , 2012, EMBO molecular medicine.
[9] Kerstin Schneeberger,et al. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer , 2012, EMBO molecular medicine.
[10] C. Harley,et al. The telomerase activator TA‐65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence , 2011, Aging cell.
[11] Brandon G. King,et al. Intensive meditation training, immune cell telomerase activity, and psychological mediators , 2011, Psychoneuroendocrinology.
[12] C. Harley,et al. A natural product telomerase activator as part of a health maintenance program. , 2011, Rejuvenation research.
[13] Helen Christensen,et al. Is telomere length a biomarker of aging? A review. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.
[14] C. Harley,et al. Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes1 , 2008, The Journal of Immunology.
[15] P. Klatt,et al. Telomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice , 2008, Cell.
[16] Jue Lin,et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. , 2008, The Lancet. Oncology.
[17] M. Blasco,et al. Cellular Senescence in Cancer and Aging , 2007, Cell.
[18] P. Lansdorp,et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.
[19] M. Blasco. Telomeres and human disease: ageing, cancer and beyond , 2005, Nature Reviews Genetics.
[20] S. Chanock,et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. , 2005, The New England journal of medicine.
[21] M. Blasco,et al. Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice , 2005, Oncogene.
[22] K. Collins,et al. Telomerase in the human organism , 2002, Oncogene.
[23] T. Lange. Protection of mammalian telomeres , 2002, Oncogene.
[24] Margaret A. Strong,et al. The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability , 2001, Cell.
[25] E. Blackburn. Switching and Signaling at the Telomere , 2001, Cell.
[26] M. Blasco,et al. Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc−/− mice with short telomeres , 2001, EMBO reports.
[27] María A Blasco,et al. Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA , 1997, Cell.
[28] C. Harley,et al. Telomeres shorten during ageing of human fibroblasts , 1990, Nature.